Melanoma Insights for Professionals brings you conversations with leading multidisciplinary experts who break down the latest research and best practice into what it actually means in the clinic. Developed by Melanoma Institute Australia, this podcast helps healthcare professionals stay ahead of developments in melanoma and complex skin cancer—while uncovering the thinking behind expert clinical decision-making.
In this episode from MIA’s podcast Melanoma Insights for Professionals , our experts explore the critical role of multidisciplinary collaboration in delivering contemporary melanoma care. Hear how melanoma multidisciplinary teams (MDTs) bring together diverse expertise to navigate increasingly complex treatment pathways, discuss challenging cases and identify opportunities for patients to…
In our final episode of our special vodcast series, Redefining Immunotherapy: Lessons from Melanoma , our experts discuss the future of immunotherapy, separating hype from reality and exploring the next frontier of cancer treatment. From cellular therapies and personalised cancer vaccines to mRNA technology and biomarker-driven treatment selection, the panel examines the innovations that could…
In our fourth episode of our special vodcast series, Redefining Immunotherapy: Lessons from Melanoma , our experts discuss one of the most rapidly evolving areas in melanoma care: immunotherapy treatment strategy. Drawing on decades of combined clinical experience, the panel explores how treatment paradigms are shifting from decisions around monotherapy versus combination immunotherapy, to…
Here's a sneak peak for our upcoming episode of Redefining Immunotherapy: Lessons from Melanoma. In this episode, our experts discuss one of the most rapidly evolving areas in melanoma care: immunotherapy treatment strategy. Look out for Episode 4, Melanoma Treatment Strategy: Expert Perspectives , dropping on Monday 1 June.
In our third episode of our special vodcast series, Redefining Immunotherapy: Lessons from Melanoma , our experts focus on one of the most important challenges in modern cancer care: immunotherapy toxicity. From subtle early warning signs to life-threatening immune-related adverse events, this episode explores how clinicians can better predict, recognise and manage toxicity while still maximising…
In our second episode of our special vodcast series, Redefining Immunotherapy: Lessons from Melanoma , our experts tackle one of the biggest challenges in modern oncology: how do we make smarter immunotherapy decisions for individual patients? The panel explores the real-world factors that shape treatment selection in advanced melanoma; from tumour burden, brain and liver metastases, and BRAF…
In this opening episode of our special vodcast series “Redefining Immunotherapy: Lessons from Melanoma”, our world-leading Medical Oncologists set the stage for a compelling five-part series exploring how immunotherapy is reshaping cancer care. Led by Prof Georgina Long AO, this engaging discussion unpacks how tumours evade the immune system, how checkpoint inhibitors work and why responses can be…
As patients transition from treatment to routine monitoring, clinicians play a crucial part in detecting recurrence early, supporting wellbeing, and guiding patients through survivorship. In the latest episode of our podcast Melanoma Insights for Professionals, we explore the essential role of follow-up care in melanoma management. Our multidisciplinary experts provide an engaging and practical…
As melanoma in situ (MIS) diagnoses rise, concerns about overdiagnosis are growing — with real implications for patients, clinicians and the health system. In this episode of our podcast Melanoma Insights for Professionals, experts from dermatology, pathology, psychology and research come together to explore the drivers of overdiagnosis, the psychological impact of an MIS label, and the role of…
In this episode, we explore how melanoma risk prediction tools are transforming clinical decision-making for newly diagnosed patients. These tools, developed by Melanoma Institute Australia and freely available at melanomarisk.org.au , help clinicians tailor care and improve outcomes. Our multidisciplinary experts provide practical guidance on using tools to predict sentinel node metastasis,…
